SoftBank's Q3 13F shows it exited Satellogic and cut Nu Holdings to 16.8 million shares from 17.8 million, with no new positions.
Business Wire Press Release.
AbCellera Biologics (ABCL) has an average rating of buy and mean price target of $16.70, according t
AbCellera shares skyrocket 121% as positive ABCL635 data, major partnerships and a stronger financial position boost investor confidence.
VANCOUVER, British Columbia, September 16, 2026--AbCellera Announces Presentation of Phase 2 Data for ABCL635 at the IMS World Congress on Menopause 2026
This is the newest page. Registered accounts read further back.